Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: LoLoLoLita who wrote (4260)	1/4/1998 2:02:00 AM
From: Cacaito	Read Replies (2) \| Respond to of 23519

First Call estimates: 1998 $0.90, 1999 $1.62 From Baseline (R), service provided via E-trade. My comments: 1998 estimates will hardly support even current stock price, except for just stagnation pending 1999 better numbers. NJ lines production up, and double their sales. But lower margins ( due to International sales and lower US margins, plus capital expenses). results in $0.90 in 1998 (stock price from $10 to $20, PE 10 to 20) But Ireland plant lower costs (ready in one year?) and a huge increase in production and sales ( 4 or 5 times actual sales, this is double the 1998 sales). Viagra out during the spring or summer and a rebound in sales after the real distribution of both markets stabilizes. It takes us to the 1999 $1.62 And a stock price of about $30 to $40 (PE 20 to 25). Not bad for buyers at the actual price and even for the $20 buyers, but all this will be with big rides up and down.